Malignant neoplasm of urinary bladder

Known as: Malignant neoplasm of bladder, part unspecified, Malignant Bladder Tumor, Malignant Tumor of Urinary Bladder 
A primary or metastatic malignant neoplasm involving the bladder.
National Institutes of Health

Related topics

Related topics

19 relations
Benign neoplasm of bladderBladder papillomaCarcinoma, Transitional CellHRAS1 oncogene
(More)

Broader (6)

Bladder NeoplasmNeoplasm, uncertain whether benign or malignantNeoplasmsUrinary Bladder
(More)

Narrower (5)

Carcinoma of bladderMalignant neoplasm of dome of bladderMalignant neoplasm of lateral wall of bladderMalignant neoplasm of ureteric orifice
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Bladder cancer
Bladder cancer is a heterogeneous disease, with 70% of patients presenting with superficial tumours, which tend to recur but are… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Micro-RNA profiling in kidney and bladder cancers.
OBJECTIVES Micro-RNAs are a group of small noncoding RNAs with modulator activity of gene expression. Recently, micro-RNA genes… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
BACKGROUND The noninvasive identification of bladder tumors may improve disease control and prevent disease progression. Aberrant… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
BACKGROUND Many reported associations between common genetic polymorphisms and complex diseases have not been confirmed in… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Amplification/overexpression of a mitotic kinase gene in human bladder cancer.
BACKGROUND The mitotic kinase-encoding gene STK15/BTAK/ AuroraA is associated with aneuploidy and transformation when… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.
PURPOSE To evaluate our long-term experience with patients treated uniformly with radical cystectomy and pelvic lymph node… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.
We investigated the aberrant promoter methylation profile of bladder cancers and correlated the data with clinicopathological… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.
We analyzed the possible prognostic value of the recently discovered fibroblast growth factor receptor 3 (FGFR3) mutations in… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.
BACKGROUND Tumor stage, histologic grade, and regional lymph node status are currently used to obtain prognostic information… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Identification of p53 gene mutations in bladder cancers and urine samples.
Although bladder cancers are very common, little is known about their molecular pathogenesis. In this study, invasive bladder… (More)
Is this relevant?